Koning GA - Search Results

1

Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.

Koning GA, Schiffelers RM, Wauben MH, Kok RJ, Mastrobattista E, Molema G, ten Hagen TL, Storm G. Koning GA, et al. Arthritis Rheum. 2006 Apr;54(4):1198-208. doi: 10.1002/art.21719. Arthritis Rheum. 2006. PMID: 16575845 Free article.

2

Targeting of liposomes to angiogenic endothelial cells.

Schiffelers RM, Molema G, Ten Hagen TL, Janssen AP, Schraa AJ, Kok RJ, Koning GA, Storm G. Schiffelers RM, et al. Among authors: koning ga. Cell Mol Biol Lett. 2002;7(2):255. Cell Mol Biol Lett. 2002. PMID: 12097939 No abstract available.

3

Endothelial cells at inflammatory sites as target for therapeutic intervention.

Koning GA, Schiffelers RM, Storm G. Koning GA, et al. Endothelium. 2002;9(3):161-71. doi: 10.1080/10623320213631. Endothelium. 2002. PMID: 12380641 Review.

4

Ligand-targeted liposomes directed against pathological vasculature.

Schiffelers RM, Molema G, ten Hagen TL, Janssen AP, Schraa AJ, Kok RJ, Koning GA, Storm G. Schiffelers RM, et al. Among authors: koning ga. J Liposome Res. 2002 Feb-May;12(1-2):129-35. doi: 10.1081/lpr-120004785. J Liposome Res. 2002. PMID: 12604046

5

CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis.

Boot EP, Koning GA, Storm G, Wagenaar-Hilbers JP, van Eden W, Everse LA, Wauben MH. Boot EP, et al. Among authors: koning ga. Arthritis Res Ther. 2005;7(3):R604-15. doi: 10.1186/ar1722. Epub 2005 Mar 21. Arthritis Res Ther. 2005. PMID: 15899047 Free PMC article.

6

In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium.

Everts M, Koning GA, Kok RJ, Asgeirsdóttir SA, Vestweber D, Meijer DK, Storm G, Molema G. Everts M, et al. Among authors: koning ga. Pharm Res. 2003 Jan;20(1):64-72. doi: 10.1023/a:1022298725165. Pharm Res. 2003. PMID: 12608538

7

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.

Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G. Schiffelers RM, et al. Among authors: koning ga. J Control Release. 2003 Aug 28;91(1-2):115-22. doi: 10.1016/s0168-3659(03)00240-2. J Control Release. 2003. PMID: 12932643

8

Targeting liposomes to tumor endothelial cells for neutron capture therapy.

Koning GA, Fretz MM, Woroniecka U, Storm G, Krijger GC. Koning GA, et al. Appl Radiat Isot. 2004 Nov;61(5):963-7. doi: 10.1016/j.apradiso.2004.05.020. Appl Radiat Isot. 2004. PMID: 15308176

9

OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis.

Fretz MM, Koning GA, Mastrobattista E, Jiskoot W, Storm G. Fretz MM, et al. Among authors: koning ga. Biochim Biophys Acta. 2004 Oct 11;1665(1-2):48-56. doi: 10.1016/j.bbamem.2004.06.022. Biochim Biophys Acta. 2004. PMID: 15471570 Free article.

10

Strategies for cytosolic delivery of liposomal macromolecules.

Fretz MM, Mastrobattista E, Koning GA, Jiskoot W, Storm G. Fretz MM, et al. Among authors: koning ga. Int J Pharm. 2005 Jul 25;298(2):305-9. doi: 10.1016/j.ijpharm.2005.02.040. Int J Pharm. 2005. PMID: 15941633 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters